These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8259983)

  • 1. Pyrrolo[1',2':1,2]imidazo[4,5-b]pyridines, pyrrolo- [2',1':2,3]imidazo[4,5-c]pyridines and pyrrolo[2,1-f]purines as potential benzodiazepine ligands.
    Chimirri A; Grasso S; Monforte P; Zappalà M; Genchi G
    Farmaco; 1993 Sep; 48(9):1261-9. PubMed ID: 8259983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonists.
    Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Romagnoli R; Zaid NA; Moorman AR; Merighi S; Varani K; Borea PA
    J Med Chem; 2005 Jul; 48(14):4697-701. PubMed ID: 16000006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and benzodiazepine receptor binding of 1H-pyrrolo[2,1-C][1,4]benzothiazines.
    Trapani G; Latrofa A; Franco M; Liso G; Genchi G
    Farmaco; 1990 Jun; 45(6):577-88. PubMed ID: 2176785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant activity of pyrrolo[1',2':1,2]imidazo[4,5-b]pyridines, pyrrolo[2',1':2,3]imidazo[4,5-c] pyridines and pyrrolo[2,1-f]purines in DBA/2 mice.
    De Sarro A; De Sarro G; Chimirri A; Grasso S; Monforte AM; Zappalà M
    Gen Pharmacol; 1994 Sep; 25(5):1027-31. PubMed ID: 7835620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and benzodiazepine receptor binding of 5H-pyrido[2,1-C][1,4]benzothiazines.
    Trapani G; Latrofa A; Franco M; Liso G; Genchi G
    Farmaco; 1990 Jun; 45(6):589-602. PubMed ID: 2176786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and benzodiazepine receptors affinity of 2,3-dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinolin-1-one and 3-carbethoxy-4-phenylquinoline derivatives.
    Anzini M; Cappelli A; Vomero S; Cagnotto A; Skorupska M
    Farmaco; 1992 Feb; 47(2):191-202. PubMed ID: 1324688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological properties of derivatives of pyrrolo(3,4-d)pyrimidines and pyrrolo(3,4-b)pyridines (I).
    Tarzia G; Panzone G; Carminati P; Schiatti P; Selva D
    Farmaco Sci; 1976 Feb; 31(2):81-97. PubMed ID: 1261668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiviral activity of an imidazo[1,2-a]pyrrolo[2,3-c]pyridine series against the bovine viral diarrhea virus.
    Chezal JM; Paeshuyse J; Gaumet V; Canitrot D; Maisonial A; Lartigue C; Gueiffier A; Moreau E; Teulade JC; Chavignon O; Neyts J
    Eur J Med Chem; 2010 May; 45(5):2044-7. PubMed ID: 20149501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New 2,3-substituted 4,7-dihydro-6-(1'H-pyrazol-3'-yl)pyrazolo[1,5-a] pyrimidin-7-ones and related compounds: synthesis and benzodiazepine receptor binding study.
    Selleri S; Bruni F; Costanzo A; Guerrini G; Casilli ML; Giusti L; Lucacchini A; Martini C
    Farmaco; 1995 Oct; 50(10):679-87. PubMed ID: 8590575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipyrazolo[5,4-b:3',4'-d]pyridines. Synthesis, inhibition of benzodiazepine receptor binding and structure-activity relationships.
    Melani F; Cecchi L; Colotta V; Filacchioni G; Martini C; Giannaccini G; Lucacchini A
    Farmaco; 1989 Jun; 44(6):585-94. PubMed ID: 2553037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel anellated pyrazoloquinolin-3-ones: synthesis and in vitro BZR activity.
    Ferlin MG; Chiarelotto G; Dall'Acqua S; Maciocco E; Mascia MP; Pisu MG; Biggio G
    Bioorg Med Chem; 2005 May; 13(10):3531-41. PubMed ID: 15848766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationship studies in peripheral benzodiazepine receptor ligands related to alpidem.
    Cappelli A; Giuliani G; Valenti S; Anzini M; Vomero S; Giorgi G; Sogliano C; Maciocco E; Biggio G; Concas A
    Bioorg Med Chem; 2008 Mar; 16(6):3428-37. PubMed ID: 18294852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]RY 80: A high-affinity, selective ligand for gamma-aminobutyric acidA receptors containing alpha-5 subunits.
    Skolnick P; Hu RJ; Cook CM; Hurt SD; Trometer JD; Liu R; Huang Q; Cook JM
    J Pharmacol Exp Ther; 1997 Nov; 283(2):488-93. PubMed ID: 9353361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of substituted [18F]imidazo[1,2-a]pyridines and [18F]pyrazolo[1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography.
    Fookes CJ; Pham TQ; Mattner F; Greguric I; Loc'h C; Liu X; Berghofer P; Shepherd R; Gregoire MC; Katsifis A
    J Med Chem; 2008 Jul; 51(13):3700-12. PubMed ID: 18557607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent, orally active corticotropin-releasing factor receptor-1 antagonists containing a tricyclic pyrrolopyridine or pyrazolopyridine core.
    Dyck B; Grigoriadis DE; Gross RS; Guo Z; Haddach M; Marinkovic D; McCarthy JR; Moorjani M; Regan CF; Saunders J; Schwaebe MK; Szabo T; Williams JP; Zhang X; Bozigian H; Chen TK
    J Med Chem; 2005 Jun; 48(12):4100-10. PubMed ID: 15943483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anthelmintic activity of 7-substituted 3,4a-dimethyl-4a,5a,8a,8b-tetrahydro-6H-pyrrolo[3',4':4,5]furo[3,2-b]pyridine-6,8(7H)-diones.
    Jeschke P; Harder A; Etzel W; Gau W; Göhrt A; Benet-Buchholz J; Thielking G
    Bioorg Med Chem Lett; 2005 May; 15(9):2375-9. PubMed ID: 15837328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase.
    Patnaik S; Stevens KL; Gerding R; Deanda F; Shotwell JB; Tang J; Hamajima T; Nakamura H; Leesnitzer MA; Hassell AM; Shewchuck LM; Kumar R; Lei H; Chamberlain SD
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3136-40. PubMed ID: 19394223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on compounds with psychotropic activity. IX--Synthesis of 6-p-methoxyphenylpyrrolo[2,1-d][1,5]benzothiazepines and evaluation of their affinities for BDZ and GABA receptor subtypes.
    Nacci V; Fiorini I; Garofalo A; Cagnotto A
    Farmaco; 1990 May; 45(5):545-58. PubMed ID: 2171544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status epilepticus alters zolpidem sensitivity of [3H]flunitrazepam binding in the developing rat brain.
    Laurén HB; Lopez-Picon FR; Kukko-Lukjanov TK; Uusi-Oukari M; Holopainen IE
    Neuroscience; 2007 May; 146(2):802-11. PubMed ID: 17360122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.